The MiR-200 Family of MicroRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
Overview
Authors
Affiliations
The miR-200 family of microRNAs (miRNAs) includes miR-200a, miR-200b, miR-200c, miR-141 and miR-429, five evolutionarily conserved miRNAs that are encoded in two clusters of hairpin precursors located on human chromosome 1 (miR-200b, miR-200a and miR-429) and chromosome 12 (miR-200c and miR-141). The mature -3p products of the precursors are abundantly expressed in epithelial cells, where they contribute to maintaining the epithelial phenotype by repressing expression of factors that favor the process of epithelial-to-mesenchymal transition (EMT), a key hallmark of oncogenic transformation. Extensive studies of the expression and interactions of these miRNAs with cell signaling pathways indicate that they can exert both tumor suppressor- and pro-metastatic functions, and may serve as biomarkers of epithelial cancers. This review provides a summary of the role of miR-200 family members in EMT, factors that regulate their expression, and important targets for miR-200-mediated repression that are involved in EMT. The second part of the review discusses the potential utility of circulating miR-200 family members as diagnostic/prognostic biomarkers for breast, colorectal, lung, ovarian, prostate and bladder cancers.
Mendez-Garcia A, Bravo-Vazquez L, Sahare P, Paul S Genes (Basel). 2025; 16(2).
PMID: 40004477 PMC: 11855573. DOI: 10.3390/genes16020148.
The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.
Dieli R, Lioy R, Crispo F, Cascelli N, Martinelli M, Lerose R Biomolecules. 2025; 15(2).
PMID: 40001578 PMC: 11853026. DOI: 10.3390/biom15020275.
Zhao S, Chen M, Chen F, Gao Z, Li X, Hu L iScience. 2025; 28(2):111819.
PMID: 39995876 PMC: 11849663. DOI: 10.1016/j.isci.2025.111819.
Ebrahimian Vargahan S, Barati M, Roudbari M, Eini M, Hosseini A Bioimpacts. 2025; 15:30032.
PMID: 39963567 PMC: 11830142. DOI: 10.34172/bi.30032.
Kishta M, Khamis A, Am H, Elshaar A, Gul D Transl Oncol. 2024; 51:102216.
PMID: 39615277 PMC: 11647223. DOI: 10.1016/j.tranon.2024.102216.